{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:14:32Z","timestamp":1762161272015,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T00:00:00Z","timestamp":1497052800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fundaci\u00f3n Santos y de la Garza-Evia, I.B.P."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10792-017-0588-1","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T01:23:19Z","timestamp":1497057799000},"page":"1243-1249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1419-2109","authenticated-orcid":false,"given":"Alejandro","family":"Rodriguez-Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Macias-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Gonzalez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,10]]},"reference":[{"key":"588_CR1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0002-9394(68)92086-2","volume":"66","author":"ME Corwin","year":"1968","unstructured":"Corwin ME (1968) Superior limbic keratoconjunctivitis. Am J Ophthalmol 66:338\u2013340","journal-title":"Am J Ophthalmol"},{"key":"588_CR2","first-page":"25","volume":"42","author":"FH Theodore","year":"1963","unstructured":"Theodore FH (1963) Superior limbic keratoconjunctivitis. Eye Ear Nose Throat 42:25\u201328","journal-title":"Eye Ear Nose Throat"},{"key":"588_CR3","first-page":"555","volume":"92","author":"P Wright","year":"1972","unstructured":"Wright P (1972) Superior limbic keratoconjunctivitis. Trans Ophthalmol Soc UK 92:555\u2013560","journal-title":"Trans Ophthalmol Soc UK"},{"key":"588_CR4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/eye.1989.26","volume":"3","author":"JD Nelson","year":"1989","unstructured":"Nelson JD (1989) Superior limbic keratoconjunctivitis (SLK). Eye Lond 3:180\u2013189","journal-title":"Eye Lond"},{"key":"588_CR5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archopht.1970.00990040483016","volume":"84","author":"FH Theodore","year":"1970","unstructured":"Theodore FH, Ferry AP (1970) Superior limbic keratoconjunctivitis: clinical and pathologic correlations. Arch Ophthalmol 84:481\u2013484","journal-title":"Arch Ophthalmol"},{"key":"588_CR6","first-page":"93","volume":"87","author":"G Mendoza-Adam","year":"2013","unstructured":"Mendoza-Adam G, Rodriguez-Garcia A (2013) Superior limbic keratoconjunctivitis (SLK) and its association to systemic diseases. Rev Mex Oftalmol 87:93\u201399","journal-title":"Rev Mex Oftalmol"},{"key":"588_CR7","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0161-6420(95)30843-3","volume":"102","author":"EF Kadrmas","year":"1995","unstructured":"Kadrmas EF, Bartley GB (1995) Superior limbic keratoconjunctivitis: a prognostic sign for severe Grave\u00b4s ophthalmopathy. Ophthalmology 102:1472\u20131475","journal-title":"Ophthalmology"},{"key":"588_CR8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1442-9071.2000.00284.x","volume":"28","author":"I Cher","year":"2000","unstructured":"Cher I (2000) Superior limbic keratoconjunctivitis: multifactorial mechanical pathogenesis. Clin Exp Ophthalmol 28:181\u2013184","journal-title":"Clin Exp Ophthalmol"},{"key":"588_CR9","first-page":"85","volume":"14","author":"RA Eiferman","year":"1979","unstructured":"Eiferman RA, Wilkins EL (1979) Immunological aspects of superior limbic keratoconjunctivitis. Can J Ophthalmol 14:85\u201387","journal-title":"Can J Ophthalmol"},{"key":"588_CR10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajo.2007.10.025","volume":"145","author":"YC Sun","year":"2008","unstructured":"Sun YC, Hsiao CH, Chen WL, Wang IJ, Hou YC, Hu FR (2008) Conjunctival resection combined with Tenon layer excision and the involvement of mast cells in superior limbic keratoconjunctivitis. Am J Ophthalmol 145:445\u2013452","journal-title":"Am J Ophthalmol"},{"key":"588_CR11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00003226-200111000-00006","volume":"20","author":"E Goto","year":"2001","unstructured":"Goto E, Shimmura S, Shimazaki J, Tsubota K (2001) Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 20:807\u2013810","journal-title":"Cornea"},{"key":"588_CR12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0002-9394(88)90245-0","volume":"105","author":"Y Ohashi","year":"1998","unstructured":"Ohashi Y, Watanabe H, Kinoshita S, Hosotani H, Umemoto M, Manabe R (1998) Vitamin-A eye drops for superior limbic keratoconjunctivitis. Am J Ophthalmol 105:523\u2013527","journal-title":"Am J Ophthalmol"},{"key":"588_CR13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-9394(14)76673-5","volume":"85","author":"PC Donshik","year":"1978","unstructured":"Donshik PC, Collin HB, Foster CS, Cavanagh HD, Boruchoff SA (1978) Conjunctival resection treatment and ultrastructural histopathology of superior limbic keratoconjunctivitis. Am J Ophthalmol 85:101\u2013110","journal-title":"Am J Ophthalmol"},{"key":"588_CR14","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0161-6420(84)34207-5","volume":"91","author":"GA Passons","year":"1984","unstructured":"Passons GA, Wood TO (1984) Conjunctival resection for superior limbic keratoconjunctivitis. Ophthalmology 91:966\u2013968","journal-title":"Ophthalmology"},{"key":"588_CR15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0161-6420(86)33766-7","volume":"93","author":"IJ Udell","year":"1986","unstructured":"Udell IJ, Kenyon KR, Sawa M, Dohlman CH (1986) Treatment of superior limbic keratoconjunctivitis by thermocauterization of the superior bulbar conjunctiva. Ophthalmology 93:162\u2013166","journal-title":"Ophthalmology"},{"key":"588_CR16","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1001\/archopht.1982.01030040912008","volume":"100","author":"BJ Mondino","year":"1982","unstructured":"Mondino BJ, Zaidman GW, Salamon SW (1982) Use of pressure patching and soft contact lenses in superior limbic keratoconjunctivitis. Arch Ophthalmol 100:1932\u20131934","journal-title":"Arch Ophthalmol"},{"key":"588_CR17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0002-9394(14)71647-2","volume":"124","author":"HY Yang","year":"1997","unstructured":"Yang HY, Fujishima H, Toda I, Shimazaki J, Tsubota K (1997) Lacrimal punctal occlusion for the treatment of superior limbic keratoconjunctivitis. Am J Ophthalmol 124:80\u201387","journal-title":"Am J Ophthalmol"},{"key":"588_CR18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/00006324-199810000-00015","volume":"75","author":"AG Kabat","year":"1998","unstructured":"Kabat AG (1998) Lacrimal occlusion therapy for the treatment of superior limbic keratoconjunctivitis. Optom Vis Sci 75:714\u2013718","journal-title":"Optom Vis Sci"},{"key":"588_CR19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/ICO.0b013e318030d230","volume":"26","author":"YC Shen","year":"2007","unstructured":"Shen YC, Wang CY, Tsai HY, Lee YF (2007) Supratarsal triamcinolone injection in the treatment of superior limbic keratoconjunctivitis. Cornea 26:423\u2013426","journal-title":"Cornea"},{"key":"588_CR20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ajo.2008.07.047","volume":"147","author":"FW Fraunfelder","year":"2009","unstructured":"Fraunfelder FW (2009) Liquid nitrogen cryotherapy of superior limbic keratoconjunctivitis. Am J Ophthalmol 147:234\u2013238","journal-title":"Am J Ophthalmol"},{"key":"588_CR21","first-page":"46","volume":"13","author":"YS Chun","year":"2014","unstructured":"Chun YS, Kim JC (2014) Treatment of superior limbic keratoconjunctivitis using botulinum toxin A. Korean J Optom Vis SCi 13:46\u201352","journal-title":"Korean J Optom Vis SCi"},{"key":"588_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/ITO.0b013e3182256b7f","volume":"9","author":"J Liu","year":"2011","unstructured":"Liu J, Sheha H, Fu Y, John T, Tseng SC (2011) A new surgical approach of amniotic membrane transplantation for superior limbic keratoconjunctivitis. Techn Ophthalmol 9:41\u201343","journal-title":"Techn Ophthalmol"},{"key":"588_CR23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/ICO.0b013e3181d1d1cc","volume":"29","author":"O Gris","year":"2010","unstructured":"Gris O, Plazas A, Lerma E, G\u00fcell JL, Pelegr\u00edn L, El\u00edes D (2010) Conjunctival resection with and without amniotic membrane graft for the treatment of superior limbic keratoconjunctivitis. Cornea 29:1025\u20131030","journal-title":"Cornea"},{"key":"588_CR24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/ICO.0000000000000013","volume":"33","author":"JM Ahn","year":"2014","unstructured":"Ahn JM, Choi CY, Seo KY (2014) Surgical approach with high-frequency radiowave electrosurgery for superior limbic keratoconjunctivitis. Cornea 33:210\u2013214","journal-title":"Cornea"},{"key":"588_CR25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3341\/jkos.2014.55.3.443","volume":"55","author":"WS Kim","year":"2014","unstructured":"Kim WS, Wee SW, Kim JC (2014) Two cases of superior limbic keratoconjunctivitis treated with bevacizumab and triamcinolone injection. J Korean Ophthalmol Soc 55:443\u2013448","journal-title":"J Korean Ophthalmol Soc"},{"key":"588_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5005\/jp\/books\/12072_25","volume-title":"Ocular surface disorders","author":"JC Sanchez","year":"2013","unstructured":"Sanchez JC, Mesa D, Avendafio E (2013) Superior limbic keratoconjunctivitis. In: Benitez del Castillo JM, Lemp MA (eds) Ocular surface disorders, vol 25. JP Medical, LTD, New Delhi, pp 215\u2013219"},{"key":"588_CR27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0161-6420(97)30223-1","volume":"104","author":"S Bonini","year":"1997","unstructured":"Bonini S, Schiavone M, Bonini S, Magrini L, Lischetti P, Lambiase A, Bucci MG (1997) Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis. Ophthalmology 104:849\u2013853","journal-title":"Ophthalmology"},{"key":"588_CR28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000236505","volume":"101","author":"JM Yanni","year":"1993","unstructured":"Yanni JM, Weimer LK, Glaser RL, Lang LS, Robertson SM, Spellman JM (1993) Effect of lodoxamide on in vitro and in vivo conjunctival immediate hypersensitivity responses in rats. Int Arch Allergy Immunol 101:102\u2013106","journal-title":"Int Arch Allergy Immunol"},{"key":"588_CR29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-9394(14)74786-5","volume":"113","author":"DR Caldwell","year":"1992","unstructured":"Caldwell DR, Verin P, Hartwich-Young R (1992) Efficacy and safety of lodoxamide 0.1% versus cromolyn sodium 4% in patients with vernal keratoconjunctivitis. Am J Ophthalmol 113:632\u2013637","journal-title":"Am J Ophthalmol"},{"key":"588_CR30","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/bjo.82.10.1135","volume":"82","author":"D Denis","year":"1998","unstructured":"Denis D, Bloch-Michel E, Verin P, Sebastiani A, Tazartes M, Helleboid L, Di Giovanni A, Lecorvec M (1998) Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA. Br J Ophthalmol 82:1135\u20131138","journal-title":"Br J Ophthalmol"},{"key":"588_CR31","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0002-9394(14)72177-4","volume":"120","author":"RD Grutzmacher","year":"1995","unstructured":"Grutzmacher RD, Foster RS, Feiler LS (1995) Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis. Am J Ophthalmol 120:400\u2013402","journal-title":"Am J Ophthalmol"},{"key":"588_CR32","first-page":"181","volume":"29","author":"M Khalil","year":"2013","unstructured":"Khalil M, Malik TG, Munawar S (2013) Use of silver nitrate in superior limbic keratoconjunctivitis. Pak J Ophthalmol 29:181\u2013182","journal-title":"Pak J Ophthalmol"},{"key":"588_CR33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ajo.2013.12.027","volume":"157","author":"Y Takahashi","year":"2014","unstructured":"Takahashi Y, Ichinose A, Kakizaki H (2014) Topical rebamipide treatment for superior limbic keratoconjunctivitis in patients with thyroid eye disease. Am J Ophthalmol 157:807\u2013812","journal-title":"Am J Ophthalmol"},{"key":"588_CR34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9394(02)01975-X","volume":"135","author":"N Yokoi","year":"2003","unstructured":"Yokoi N, Komuro A, Maruyama K, Tsuzuki M, Miyajima S, Kinoshita S (2003) New surgical treatment for superior limbic keratoconjunctivitis and its association with conjunctivochalasis. Am J Ophthalmol 135:303\u2013308","journal-title":"Am J Ophthalmol"},{"key":"588_CR35","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1167\/iovs.10-6324","volume":"52","author":"YC Sun","year":"2011","unstructured":"Sun YC, Hsiao CH, Chen WL, Hu FR (2011) Overexpression of matrix metalloproteinase-1 (MMP-1) and MMP-3 in superior limbic keratoconjunctivitis. Invest Ophthalmol Vis Sci 52:3701\u20133705","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"588_CR36","first-page":"404","volume":"41","author":"DQ Li","year":"2000","unstructured":"Li DQ, Meller D, Liu Y, Tseng SC (2000) Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts. Invest Ophthalmol Vis Sci 41:404\u2013410","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"588_CR37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3109\/02713689609017652","volume":"15","author":"A Matsuda","year":"1996","unstructured":"Matsuda A, Tagawa Y, Matsuda H (1996) Cytokeratin and proliferative cell nuclear antigen expression in superior limbic keratoconjunctivitis. Curr Eye Res 15:1033\u20131038","journal-title":"Curr Eye Res"},{"key":"588_CR38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0021-5155(99)00021-0","volume":"43","author":"A Matsuda","year":"1999","unstructured":"Matsuda A, Tagawa Y, Matsuda H (1999) TGF-beta2, tenascin, and integrin beta1 expression in superior limbic keratoconjunctivitis. Jpn J Ophthalmol 43:251\u2013256","journal-title":"Jpn J Ophthalmol"},{"key":"588_CR39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.2007.00528.x","volume":"217","author":"JP Kinet","year":"2007","unstructured":"Kinet JP (2007) The essential role of mast cells in orchestrating inflammation. Immunol Rev 217:5\u20137","journal-title":"Immunol Rev"},{"key":"588_CR40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9394(14)74981-5","volume":"100","author":"JV Greiner","year":"1985","unstructured":"Greiner JV, Peace DG, Baird RS, Allansmith MR (1985) Effects of eye rubbing on the conjunctiva as a model of ocular inflammation. Am J Ophthalmol 100:45\u201350","journal-title":"Am J Ophthalmol"},{"key":"588_CR41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0091-6749(87)90015-7","volume":"80","author":"GF Murphy","year":"1987","unstructured":"Murphy GF, Austen KF, Fonferko E, Sheffer AL (1987) Morphologically distinctive forms of cutaneous mast cell degranulation induced by cold and mechanical stimuli: an ultrastructural study. J Allergy Clin Immunol 80:603\u2013611","journal-title":"J Allergy Clin Immunol"},{"key":"588_CR42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.20062211","volume":"204","author":"Z Allakhverdi","year":"2007","unstructured":"Allakhverdi Z, Comeau MR, Jessup HK (2007) Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 204:253\u2013258","journal-title":"J Exp Med"},{"key":"588_CR43","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/ICO.0000000000000624","volume":"34","author":"YC Sun","year":"2015","unstructured":"Sun YC, Liou HM, Shen EP, Hu FR (2015) Stem cell factor and thymic stromal lymphopoietin overexpression with correlation to mast cells in superior limbic keratoconjunctivitis. Cornea 34:1487\u20131492","journal-title":"Cornea"},{"key":"588_CR44","first-page":"129","volume":"19","author":"J Confino","year":"1987","unstructured":"Confino J, Brown SI (1987) Treatment of superior limbic keratoconjunctivitis with topical cromolyn sodium. Ann Ophthalmol 19:129\u2013131","journal-title":"Ann Ophthalmol"},{"key":"588_CR45","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00003226-200211000-00009","volume":"21","author":"IJ Udell","year":"2002","unstructured":"Udell IJ, Guidera AC, Madani-Becker J (2002) Ketotifen fumarate treatment of superior limbic keratoconjunctivitis. Cornea 21:778\u2013780","journal-title":"Cornea"},{"key":"588_CR46","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/bjo.2007.122044","volume":"91","author":"F Mantelli","year":"2007","unstructured":"Mantelli F, Santos MS, Petitti T, Sgrulletta R, Cortes M, Lambiase A, Bonini S (2007) Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis. Br J Ophthalmol 91:1656\u20131661","journal-title":"Br J Ophthalmol"},{"key":"588_CR47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/ICO.0b013e318033bd25","volume":"27","author":"A Sahin","year":"2008","unstructured":"Sahin A, Bozkurt B, Irkec M (2008) Topical cyclosporine-A in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up. Cornea 27:193\u2013195","journal-title":"Cornea"},{"key":"588_CR48","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/S0161-6420(03)00538-4","volume":"110","author":"HD Perry","year":"2003","unstructured":"Perry HD, Doshi-Carnevale S, Donnenfeld ED, Kornstein HS (2003) Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis. Ophthalmology 110:1578\u20131581","journal-title":"Ophthalmology"},{"key":"588_CR49","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/ICO.0b013e318295e6b9","volume":"32","author":"GD Kymionis","year":"2013","unstructured":"Kymionis GD, Klados NE, Kontadakis GA, Mikropoulos DG (2013) Treatment of superior limbic keratoconjunctivitis with topical tacrolimus 0.03% ointment. Cornea 32:1499\u20131501","journal-title":"Cornea"},{"key":"588_CR50","first-page":"2686","volume":"37","author":"SM Whitcup","year":"1996","unstructured":"Whitcup SM, Chan CC, Luyo DA, Bo P, Li Q (1996) Topical cyclosporine inhibits mast cell-mediated conjunctivitis. Invest Ophthalmol Vis Sci 37:2686\u20132693","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-017-0588-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0588-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0588-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T17:29:47Z","timestamp":1569432587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-017-0588-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,10]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["588"],"URL":"https:\/\/doi.org\/10.1007\/s10792-017-0588-1","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"type":"print","value":"0165-5701"},{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2017,6,10]]}}}